Skip to content
TrackPodcasts
businessDec 19, 20221:20:16pending

Lionel Hutz on Liquidia's patent battle $LQDA

About this episode

Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR).

Lionel's LQDA write up: https://lionelhutz.substack.com/p/waiting-with-bated-breath-for-liquidia

Chapters 

  • 0:00 Intro 
  • 2:50 LQDA overview 
  • 8:05 Diving into the patent background 
  • 16:10 Breaking down the conflicting rulings on the '793 patent 
  • 19:55 Why the PTAB ruling is the most important for '793 
  • 21:55 What's so unique about the judge's ruling on '793 
  • 28:30 Why PTAB ruled the '793 patent invalid 
  • 37:40 LQDA's primary argument for invalidating '793 
  • 43:30 Discussing the expert reports around the '793 patent 
  • 53:30 Timeline to monetization and why delaying LQDA is so important for UTHR 
  • 59:00 LQDA's upside if they win 
  • 1:13:00 LQDA's cash runway

Get every episode summarized

Each time Yet Another Value Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Lionel Hutz on Liquidia's patent battle $LQDA

Yet Another Value Podcast

0:00
1:20:16

More episodes

More from Yet Another Value Podcast

View all episodes →